Hemodynamic Effects of Vecuronium, Pancuronium and Rocuronium during O2-Midazolam-Fentanyl Anesthesia in Patients with Coronary Artery Disease or Valvular Heart Diseases

2003 ◽  
Vol 44 (1) ◽  
pp. 24
Author(s):  
Young Lan Kwak ◽  
Young Jun Oh ◽  
Jong Hwa Lee ◽  
Helen Ki Shinn ◽  
Wong Chul Lee ◽  
...  
1979 ◽  
Vol 26 (3) ◽  
pp. 330-338 ◽  
Author(s):  
Christopher Y. C. Chew ◽  
John Collett ◽  
Prediman K. Shah ◽  
Bramah N. Singh

2021 ◽  
Vol 8 (2) ◽  
pp. 22
Author(s):  
Rashid Mir ◽  
Imadeldin Elfaki ◽  
Naina Khullar ◽  
Ajaz Ahmad Waza ◽  
Chandan Jha ◽  
...  

Cardiovascular diseases are the leading cause of death worldwide in different cohorts. It is well known that miRNAs have a crucial role in regulating the development of cardiovascular physiology, thus impacting the pathophysiology of heart diseases. MiRNAs also have been reported to be associated with cardiac reactions, leading to myocardial infarction (MCI) and ultimately heart failure (HF). To prevent these heart diseases, proper and timely diagnosis of cardiac dysfunction is pivotal. Though there are many symptoms associated with an irregular heart condition and though there are some biomarkers available that may indicate heart disease, authentic, specific and sensitive markers are the need of the hour. In recent times, miRNAs have proven to be promising candidates in this regard. They are potent biomarkers as they can be easily detected in body fluids (blood, urine, etc.) due to their remarkable stability and presence in apoptotic bodies and exosomes. Existing studies suggest the role of miRNAs as valuable biomarkers. A single biomarker may be insufficient to diagnose coronary artery disease (CAD) or acute myocardial infarction (AMI); thus, a combination of different miRNAs may prove fruitful. Therefore, this review aims to highlight the role of circulating miRNA as diagnostic and prognostic biomarkers in cardiovascular diseases such as coronary artery disease (CAD), myocardial infarction (MI) and atherosclerosis.


1987 ◽  
Vol 31 (6) ◽  
pp. 326
Author(s):  
C. J. FERRES ◽  
I. W. CARSON ◽  
S. M. LYONS ◽  
I. A. ORR ◽  
C. C. PATTERSON ◽  
...  

2018 ◽  
Vol 03 (02/03) ◽  
pp. 098-107
Author(s):  
Jyotsna Maddury ◽  
Indrani Garre

AbstractBecause of increase in the incidence of coronary artery disease (CAD) in younger population with increasing maternal age of pregnancy, the topic of acute myocardial infarction (AMI) during pregnancy has gained importance. Pathophysiologically AMI during pregnancy occurs more frequently due to coronary dissection, which is different in detection and management when compared with the atherosclerotic CAD. Dual antiplatelet drugs that are mandatory following AMI require modification before labor. In this review article, authors discuss in detail about the detection and management of AMI at different stages of pregnancy with the risk stratification and recommendations, including 2018 European Society of Cardiology (ESC) guidelines on “heart diseases during pregnancy.”


1977 ◽  
Vol 56 (2) ◽  
pp. 255???259 ◽  
Author(s):  
JAMES ZAIDAN ◽  
DANIEL M. PHILBIN ◽  
ROBERT ANTONIO ◽  
JOHN SAVARESE

2018 ◽  
Vol 15 (2) ◽  
pp. 21-24
Author(s):  
Ravi Sahi ◽  
Arun Sayami ◽  
Ratna Mani Gajurel ◽  
Chandra Mani Poudel ◽  
Hemant Shrestha ◽  
...  

Background and Aims: Coronary artery disease (CAD) constitute a major cause of cardiovascular morbidity and mortality worldwide with an enormous burden on healthcare resources. Prevalence and pattern of CAD in patients of rheumatic and non-rhemuatic valvular heart diseases varies widely with limited data on optimal strategies for diagnosis and treatment.Methods: This study includes 97 patients with rheumatic and non-rheumatic valvular heart disease who underwent coronary angiogram (CAG) before cardiac surgery. Patients were divided into two groups based on rheumatic heart disease (RHD) & non-rheumatic disease (Non-RHD) and correlate the patterns of CAD.Results: Out of 97 patients, 22 (22.6%) patients were found to have significant CAD. In patients with non-rheumatic origin CAD was common (15 patients, 68.1%) as compared to rheumatic origin (7 patients, 31. 8%). In rheumatic origin, the prevalence was 7(12.2%) out of 57 patients while in non-rheumatic origin, was 15(37.5%) out of 40 patients. In RHD group, all patients with CAD were found to have single vessel diease (SVD) while, in non-RHD group, 11 patients (73.3%) had SVD, 3 patients (16.7%) had double vessel disease (DVD) and one patient (5.6%) had triple vessel disease (TVD).Conclusions: Prevalence of CAD is higher in patients with non-RHD in comparison to those with RHD. We also found SVD to be the most common pattern of CAD in both rheumatic and non-rheumatic valvular heart disease.


Sign in / Sign up

Export Citation Format

Share Document